A Fara, Z Mitrev, RA Rosalia, BM Assas - Open biology, 2020 - royalsocietypublishing.org
… The term ‘cytokine storm syndrome’ is perhaps one of the critical … COVID-19 disease severity. In this review, we highlight prominent cytokine families and their potential role in COVID-19, …
L Yang, S Liu, J Liu, Z Zhang, X Wan… - Signal transduction and …, 2020 - nature.com
… by marked pro-inflammatorycytokine release in patients with severe COVID-19, leading to … Therefore, mechanisms underlying immune abnormalities in patients with COVID-19 must …
D Ragab, H Salah Eldin, M Taeimah… - Frontiers in …, 2020 - frontiersin.org
… COVID-19 poses an increasing threat to humans with a fatality rate of 6.4 % so far (4). COVID-19 … of a large amount of pro-inflammatorycytokines in an event known as “cytokine storm.” …
A Torabi, E Mohammadbagheri… - ACS chemical …, 2020 - ACS Publications
… local proinflammatorycytokine levels in the olfactory epithelium in patients with COVID-19. Biopsies of the olfactory epithelium were taken from patients with confirmed COVID-19 as …
P Conti, G Ronconi, AL Caraffa… - J Biol Regul Homeost …, 2020 - researchgate.net
… Coronavirus-19 (COVI-19) involves humans as well as animals and may cause serious damage to the respiratory tract, including the lung: coronavirus disease (COVI-19)… When COVI-19 …
M Rokni, MR Hamblin, N Rezaei - Human vaccines & …, 2020 - Taylor & Francis
… of pro-inflammatorycytokines and chemokines, secreted by immune effector cells. … cytokine storm also occurs in the recently emerged novel coronavirus disease (COVID-19). …
… cytokines in COVID-19-associated CS. We will particularly emphasize the role of GM-CSF … G-CSF cytokines and other emerging therapeutic strategies adopted to mitigate COVID-19. …
RJ Jose, A Manuel - The Lancet. Respiratory Medicine, 2020 - ncbi.nlm.nih.gov
… production of proinflammatorycytokines via activation of PAR-2 and PAR-1, 5 these drugs might be promising in ameliorating disease progression and severity of COVID-19. Bleeding …
… between these cytokines and severe or critical cases of COVID-19, we could hypothesize that anti-IL-6 and anti-TNF antibodies could be effective for reducing COVID-19 mortality. In the …